Niramai Health Analytix
PrivateLast Round
Series A
Extension
Oct 21, 2023
Total Funding Raised
$7.63M
Company Overview
Niramai Health Analytix operates in Healthcare & Life Sciences and is based in Bangalore Urban. Its latest recorded funding round was a Series A Extension round in October 2023.
Niramai Health Analytix is a healthcare technology company that offers an AI-based solution for early-stage breast cancer detection.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Niramai Health Analytix Comparables
Compare Niramai Health Analytix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| UE LifeSciences | 80% | |
| Salva Health | 77% | |
| CureMetrix | 75% |
For institutional investors. Book with your work email.
Niramai Health Analytix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 21, 2023 | ||||
| Grant | Jun 29, 2021 | ||||
| Series A | Feb 25, 2019 | ||||
| Seed | Apr 24, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Niramai Health Analytix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maharashtra State Innovation Society | Series A |
| pi Ventures | Series A, Seed, Series A Extension |
| 500 Global | Seed |
| BEENEXT Capital Management | Series A |
| Axilor Ventures | Seed, Series A, Series A Extension |
| Dream Incubator | Series A |
| Ankur Capital | Seed, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 47% MoM.
- Jun 29, 2021
Received grant funding from British International Investment.
For institutional investors. Book with your work email.
Niramai Health Analytix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Niramai Health Analytix's valuation, stock price, and market status.
Is Niramai Health Analytix a public or private company?
Niramai Health Analytix is a private company.
What is the current stock price of Niramai Health Analytix?
Niramai Health Analytix is a private company, so its shares have no public market price. Caplight tracks Niramai Health Analytix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Niramai Health Analytix worth (valuation)?
Valuation information for Niramai Health Analytix is not publicly available.
Can I buy Niramai Health Analytix stock?
Niramai Health Analytix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Niramai Health Analytix's last funding round?
Niramai Health Analytix's most recent funding round was Series A Extension on October 21, 2023.
Who are the main investors in Niramai Health Analytix?
Key investors in Niramai Health Analytix include pi Ventures, Axilor Ventures, Dream Incubator, British International Investment.
Will Niramai Health Analytix IPO soon?
No public IPO plans have been announced for Niramai Health Analytix.
How can I track Niramai Health Analytix secondary market activity?
Caplight tracks bids, offers, and trades in Niramai Health Analytix's shares on secondary markets.